Net Cash Provided by (Used in) Operating Activities |
-108K |
USD |
-42.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
107K |
USD |
+63.4% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
50B |
shares |
+100% |
Q3 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
9.69B |
shares |
+27% |
Q3 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.91K |
USD |
+1650% |
Q3 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
4.88M |
USD |
+7.16% |
Q1 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
1.25M |
USD |
0% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
4.88M |
USD |
+7.16% |
Q1 2024 |
FY 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2024 |
Q2 2025 |
Additional Paid in Capital |
67.5M |
USD |
+6.21% |
Q3 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2024 |
FY 2024 |
Interest Expense |
307K |
USD |
-3.14% |
Q3 2024 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
FY 2024 |